1. Home
  2. ICMB vs SCLX Comparison

ICMB vs SCLX Comparison

Compare ICMB & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Investcorp Credit Management BDC Inc.

ICMB

Investcorp Credit Management BDC Inc.

HOLD

Current Price

$2.82

Market Cap

40.8M

Sector

Finance

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$16.55

Market Cap

139.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICMB
SCLX
Founded
2012
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.8M
139.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ICMB
SCLX
Price
$2.82
$16.55
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
40.8K
120.8K
Earning Date
11-12-2025
11-14-2025
Dividend Yield
18.70%
N/A
EPS Growth
31.51
N/A
EPS
0.38
N/A
Revenue
$17,931,778.00
$40,360,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.75
$749.70
P/E Ratio
$7.25
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.46
$3.60
52 Week High
$3.47
$34.27

Technical Indicators

Market Signals
Indicator
ICMB
SCLX
Relative Strength Index (RSI) 47.40 41.66
Support Level $2.74 $18.34
Resistance Level $2.90 $20.62
Average True Range (ATR) 0.09 1.46
MACD -0.01 -0.39
Stochastic Oscillator 21.87 3.10

Price Performance

Historical Comparison
ICMB
SCLX

About ICMB Investcorp Credit Management BDC Inc.

Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: